Mineralys Therapeutics announces $250M common stock offering
Mineralys Therapeutics (MLYS) announced that it has commenced an underwritten public offering of $250M of shares of its common stock. Mineralys ...
Mineralys Therapeutics Announces Pricing of $175.0 Million Underwritten Public Offering of Common Stock
BofA Securities, Evercore ISI, Goldman Sachs & Co. LLC, Stifel and Wells Fargo Securities are acting as joint book-running managers for the offering. LifeSci Capital is acting as lead manager and H.C.